Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CoreLab Partners

With over 36 years of global experience, CoreLab Partners provides its clinical trial sponsors best-in-class centralized cardiac safety & efficacy services and independent medical image assessment solutions; all designed to facilitate successful new drug development in the pharmaceutical, biotechnology and medical device market sectors.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

CoreLab Partners
Elisabethstrasse 91, 80797 Munich, Germany
+49 89 2024 4497 0
Contact CoreLab Partners
Website

 Latest Content from PMHub 

Rare Diseases – not as rare as you think

White Papers and Resources | February 23, 2023 | Sciterion

Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients

Patient Recruitment: Think Global, Act Local

Videos and Podcasts | February 23, 2023 | Innovative Trials

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Together Caring for Rare Disease

Videos and Podcasts | February 23, 2023 | Medscape Education

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...

Rare and Orphan Diseases

White Papers and Resources | February 23, 2023 | Havas Life London

Why we need authentic and personalised communications in the evolving rare disease space. By Sarah Mikhailov, Managing Director, Brand at Havas Life Medicom

Origins’ Strategy Offering Explained

Videos and Podcasts | February 20, 2023 | Origins – The Patient Focused Specialists

What do we mean when we say that at Origins, we provide patient focused strategies throughout the product lifecycle? In this short video Origins’ Director Su Smith explains our strategy...

Applying Vibrotactile Stimulation to Improve Parkinson’s

Videos and Podcasts | February 16, 2023 | Impetus Digital

Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...

Impetus Digital’s Virtual Learning Programs named PM360’s Most Innovative Services of 2022

Press Releases | February 16, 2023 | Impetus Digital

About the AwardToronto, ON, December 15, 2022 — PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual...

End-to-end patient strategy: Making a treatment for patients, with patients

White Papers and Resources | February 16, 2023 | Origins – The Patient Focused Specialists

The integration of patient engagement in all stages of a product lifecycle is starting to become much more commonplace and you may start to hear the term end-to-end patient strategy...

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Press Releases | February 13, 2023 | OPEN Health

OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health

Agility – The Bedrock Way

White Papers and Resources | February 9, 2023 | Bedrock Healthcare Communications

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...